Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Therapeutics and Clinical Risk Management|September 24, 2016
Clinical analysis of contributors to the delayed gallbladder opacification following the use of water-soluble contrast mediumMing-Chang Ku, Victor C Kok, Ming-Yung Lee, et al.Aging|January 11, 2021
Late-onset epilepsy and subsequent increased risk of dementiaZhi-Ren Tsai, Han-Wei Zhang, Chun-Hung Tseng, et al.Journal of Bioinformatics and Computational Biology|February 3, 2017
Drug repurposing and therapeutic anti-microRNA predictions for inhibition of oxidized low-density lipoprotein-induced vascular smooth muscle cell-associated diseasesShun-Tsung Chen, Chien-Hung Huang, Victor C Kok, et al.Peerj|October 6, 2016
Identify potential drugs for cardiovascular diseases caused by stress-induced genes in vascular smooth muscle cellsChien-Hung Huang, Jin-Shuei Ciou, Shun-Tsung Chen, et al.Current Alzheimer Research|January 7, 2020
Long-Term Exposure to Ambient Hydrocarbons Increases Dementia Risk in People Aged 50 Years and above in TaiwanHan-Wei Zhang, Victor C Kok, Shu-Chun Chuang, et al.Plos One|December 5, 2019
Long-term ambient hydrocarbons exposure and incidence of ischemic strokeHan-Wei Zhang, Victor C Kok, Shu-Chun Chuang, et al.Plos One|September 25, 2019
Incidence of retinal vein occlusion with long-term exposure to ambient air pollutionHan-Wei Zhang, Chao-Wen Lin, Victor C Kok, et al.Breast Cancer Research and Treatment|September 23, 2021
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimensMing Shen Dai, Yin Hsun Feng, Shang Wen Chen, et al.Pageof 5